The U.S. orthopedic surgical robotics market is moving from early adoption to wider clinical adoption. According to BIS Research analysis, the market is projected to grow from $531.1 million in 2020 to $1,263.1 million by 2026, registering a 2020-2026 CAGR of approximately 15.6%.
The headline number is important, but the real story is the opportunity behind it. This is not just a robotic system sales market. It is becoming a broader ecosystem built around robotic systems, instruments and accessories, services, procedure volume, hospital adoption, and surgeon workflow integration.
The opportunity is being shaped by three forces: rising orthopedic procedure volumes, increasing hospital adoption of robotic platforms, and growing demand for precision in knee and hip procedures.
Knee and hip surgeries are among the most common elective orthopedic procedures in the U.S. Robotic systems are gaining traction because they can help reduce variability in surgical procedures and support greater precision for surgeons, hospitals, and patients.
As of 2020, more than 1,500 orthopedic surgical robotic systems had been installed in the U.S. to perform knee and hip surgeries, supporting nearly 123.5 thousand procedures in the country.
Request a Quote and get the full market forecast through 2031 before competitors act on the next growth wave.
BIS Research estimates that the U.S. orthopedic surgical robotics market will expand from $531.1 million in 2020 to $1,263.1 million by 2026. This creates an absolute revenue opportunity of around $732.0 million during 2020-2026.
In practical terms, the market is expected to become nearly 2.4 times larger by 2026 compared with 2020.
The most attractive growth pocket is instruments and accessories, not only robotic systems. By 2026, instruments and accessories are projected to reach $632.2 million, compared with $188.3 million in 2020. This segment is expected to become the largest revenue contributor by 2026.
That shift is commercially important. System sales create the installed base, but instruments, accessories, and services create recurring revenue. As more hospitals install robotic platforms and use them regularly, revenue increasingly comes from procedure-linked consumption, service contracts, upgrades, training, and workflow support.
Explore U.S. Orthopedic Imaging Modalities and Orthopedic Surgical Navigation Systems Market
Procedure volume is the clearest indicator of near-term market potential. BIS Research estimates that U.S. orthopedic surgical robotics procedure volume will rise from 123.5 thousand procedures in 2020 to 483.6 thousand procedures by 2026.
Knee procedures are expected to dominate, increasing from 92.7 thousand in 2020 to 377.2 thousand by 2026. Hip procedures are also projected to grow, from 30.8 thousand to 106.4 thousand over the same period.
This matters because robotic platforms are most commercially attractive when utilization rises. A hospital that buys a robot but uses it lightly creates limited value. A hospital that uses the robot across a growing base of knee and hip procedures becomes a stronger recurring-revenue account.
This is where procedure-volume intelligence becomes critical. BIS Research’s Surgical Procedure Volume Database helps companies evaluate procedure trends, hospital-level opportunity, physician-level volumes, and market expansion potential.
Explore the Database by Identify high-opportunity hospitals, physicians, regions, and procedures through 2031.
The market can be divided into three broad revenue pools:
Segment | 2020 Revenue | 2026 Forecast | Growth Opportunity |
Systems | $269.0 million | $453.5 million | $184.5 million |
Instruments & Accessories | $188.3 million | $632.2 million | $443.9 million |
Services | $73.8 million | $177.4 million | $103.6 million |
Total Market | $531.1 million | $1,263.1 million | $732.0 million |
The key takeaway is that hardware alone is not the highest-growth opportunity. Instruments and accessories account for the largest expansion, adding around $443.9 million between 2020 and 2026. Services also show strong growth, supported by a larger installed base and rising procedure throughput.
For companies entering or expanding in this market, the opportunity is not limited to selling robotic platforms. There is room for procedure planning tools, navigation support, disposable instruments, software upgrades, training services, maintenance, and data-driven hospital targeting.
The U.S. orthopedic surgical robotics market is still led by established players. Stryker held the largest share in 2020, supported by its Mako system and strong installed base. Zimmer Biomet, Smith & Nephew, Corin Group, and THINK Surgical also play important roles in the competitive landscape.
By 2026, Stryker is projected to remain the largest revenue contributor, reaching $714.8 million in total revenue. Smith & Nephew is projected at $200.7 million, followed by Zimmer Biomet at $143.8 million, Corin Group at $76.9 million, and THINK Surgical at $64.2 million.
This suggests that while the market remains concentrated, the opportunity is broadening as hospitals adopt more robotic-assisted orthopedic solutions and procedure volumes increase.
The South is projected to be the largest U.S. regional opportunity, with robotic orthopedic procedure volume rising from 48.64 thousand in 2020 to 193.84 thousand by 2026. The West follows, reaching 118.20 thousand procedures, while the Midwest and Northeast are projected at 98.17 thousand and 73.41 thousand, respectively.
At the state level, the largest 2026 opportunities are expected in:
• California: 69.36 thousand procedures
• Texas: 52.98 thousand procedures
• Florida: 39.06 thousand procedures
• New York: 28.14 thousand procedures
• Pennsylvania: 18.46 thousand procedures
For MedTech companies, these numbers should guide go-to-market planning. High-growth states are not just sales territories. They are priority markets for surgeon engagement, hospital targeting, training investments, and partnership development.
The U.S. orthopedic surgical robotics market is becoming a procedure-driven growth market. Companies that only track market revenue may miss where adoption is actually happening. The more useful question is: which hospitals are performing high volumes of knee and hip procedures, and which of those accounts are ready to adopt or expand robotic systems?
That is especially relevant in orthopedic robotics because adoption depends on both clinical need and commercial execution. The winning strategy is likely to combine strong technology with precise account targeting, surgeon education, procedural workflow integration, and recurring-revenue planning.
Speak with BIS Research analysts to uncover where orthopedic robotics demand is heading next- Schedule a Call
The U.S. orthopedic surgical robotics market is projected to reach $1.26 billion by 2026, growing from $531.1 million in 2020. The market is expected to add around $732.0 million in revenue opportunity during this period.
However, the bigger opportunity is not only in selling robots. It is in building a scalable ecosystem around rising procedure volumes, recurring instruments and accessories revenue, services, and hospital-level adoption.
Knee procedures will remain the core volume driver, hip procedures will add steady growth, and high-volume states such as California, Texas, and Florida will be central to commercialization strategies.
For MedTech companies, the market is entering a more competitive phase. The opportunity will belong to players that can identify the right accounts, prove clinical and economic value, and convert procedure growth into recurring revenue.
